Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 58Neoplasms 52Lung Neoplasms 33Colorectal Neoplasms 28Carcinoma, Non-Small-Cell Lung 25Prostatic Neoplasms 22Melanoma 19Pancreatic Neoplasms 17Ovarian Neoplasms 16Uterine Cervical Neoplasms 14Sarcoma 12Multiple Myeloma 12Lymphoma 11Glioma 11Glioblastoma 11Neoplasm Metastasis 10Leukemia, Myeloid, Acute 10Colonic Neoplasms 10Neoplastic Cells, Circulating 9Hematologic Neoplasms 9Lymphoma, Follicular 8Head and Neck Neoplasms 8Leukemia 7Carcinoma, Hepatocellular 7Brain Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Papillomavirus Infections 6Myelodysplastic Syndromes 6Endometrial Neoplasms 6Disease 6

Interventions

sintilimab 1danvatirsen 1catumaxomab 1aflibercept 1Zoledronic Acid 1Quality of Life 1Portasystemic Shunt, Transjugular Intrahepatic 1Octreotide 1Nutritional Status 1Interviews as Topic 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ascites × Blood Specimen Collection × Clear all
NCT06046963 2023-09-21

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Zhejiang Cancer Hospital

Phase 2 Unknown
35 enrolled
Gastrointestinal

Ascites, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡